UBS Group Upgrades CareTrust REIT (NYSE:CTRE) to Strong-Buy

CareTrust REIT (NYSE:CTRE) was upgraded by equities researchers at UBS Group to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports.

Other research analysts have also issued research reports about the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of CareTrust REIT in a research note on Wednesday, October 8th. Cantor Fitzgerald raised CareTrust REIT to a “hold” rating in a research note on Wednesday, October 1st. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy”.

CareTrust REIT Stock Up 1.6%

Shares of NYSE CTRE opened at $36.96 on Tuesday. The company has a market capitalization of $8.25 billion, a PE ratio of 27.58, a P/E/G ratio of 1.42 and a beta of 0.81. The company’s 50-day moving average is $34.81. CareTrust REIT has a fifty-two week low of $24.79 and a fifty-two week high of $37.19. The company has a current ratio of 6.98, a quick ratio of 6.98 and a debt-to-equity ratio of 0.22.

CareTrust REIT (NYSE:CTRE) last announced its earnings results on Wednesday, November 5th. The company reported $0.35 earnings per share (EPS) for the quarter. CareTrust REIT had a net margin of 61.00% and a return on equity of 7.95%. The firm had revenue of $132.44 million during the quarter.

About CareTrust REIT

CareTrust REIT, Inc is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.